LEMAITRE VASCULAR, INC. Payments to Acquire Short-term Investments
LEMAITRE VASCULAR, INC. (LMAT) reported Payments to Acquire Short-term Investments of $231.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for the quarter ending 2026-06-30 was $80.57M, a 438.70% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for the quarter ending 2026-03-31 was $150.87M, a 5114.86% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for the quarter ending 2025-12-31 was $598.31M, a 133.14% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for the quarter ending 2025-09-30 was $25.17M, a 124.82% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for fiscal 2025 was $641.33M, a 130.75% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for fiscal 2024 was $277.94M, a 1579.28% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for fiscal 2023 was $16.55M, a 106.89% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. payments to acquire short-term investments for fiscal 2022 was $8.00M, a 86.49% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $80.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $231.43M 10-Q · filed 2026-08-05 | $829.75M derived: sum of 3 quarters · filed 2026-08-05 | $854.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $150.87M 10-Q · filed 2026-05-06 | $749.18M derived: sum of 2 quarters · filed 2026-05-06 | $774.35M derived: sum of 3 quarters · filed 2026-05-06 | $789.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $598.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $623.48M derived: sum of 2 quarters · filed 2026-02-26 | $638.44M derived: sum of 3 quarters · filed 2026-08-05 | $641.33M 10-K · filed 2026-02-26 |
| 2025-09-30 | $25.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $40.12M derived: sum of 2 quarters · filed 2026-08-05 | $43.02M 10-Q · filed 2025-11-07 | $299.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $14.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.85M 10-Q · filed 2026-08-05 | $274.48M derived: sum of 3 quarters · filed 2026-08-05 | $285.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.89M 10-Q · filed 2026-05-06 | $259.52M derived: sum of 2 quarters · filed 2026-05-06 | $270.71M derived: sum of 3 quarters · filed 2026-05-06 | $279.84M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $256.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $267.82M derived: sum of 2 quarters · filed 2026-02-26 | $276.95M derived: sum of 3 quarters · filed 2026-02-26 | $277.94M 10-K · filed 2026-02-26 |
| 2024-09-30 | $11.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $20.32M derived: sum of 2 quarters · filed 2025-11-07 | $21.31M 10-Q · filed 2025-11-07 | $22.29M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.12M 10-Q · filed 2025-08-06 | $11.10M derived: sum of 3 quarters · filed 2026-02-26 | $19.43M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $991.00K 10-Q · filed 2025-05-08 | $1.97M derived: sum of 2 quarters · filed 2026-02-26 | $10.30M derived: sum of 3 quarters · filed 2026-02-26 | $16.98M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.31M derived: sum of 2 quarters · filed 2026-02-26 | $15.99M derived: sum of 3 quarters · filed 2026-02-26 | $16.55M 10-K · filed 2026-02-26 |
| 2023-09-30 | $8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $15.01M derived: sum of 2 quarters · filed 2024-11-08 | $15.57M 10-Q · filed 2024-11-08 | $15.57M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $6.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $7.24M 10-Q · filed 2024-08-08 | $7.24M derived: sum of 3 quarters · filed 2025-02-28 | $15.24M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $564.00K 10-Q · filed 2024-05-10 | $564.00K derived: sum of 2 quarters · filed 2025-02-28 | $8.56M derived: sum of 3 quarters · filed 2025-02-28 | $8.56M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $8.00M derived: sum of 2 quarters · filed 2025-02-28 | $8.00M derived: sum of 3 quarters · filed 2025-02-28 | $8.00M 10-K · filed 2025-02-28 |
| 2022-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $8.00M derived: sum of 2 quarters · filed 2023-11-07 | $8.00M 10-Q · filed 2023-11-07 | $17.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $9.64M derived: sum of 3 quarters · filed 2024-02-29 | $59.19M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $9.64M derived: sum of 2 quarters · filed 2024-02-29 | $59.19M derived: sum of 3 quarters · filed 2024-02-29 | $59.19M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $59.19M derived: sum of 2 quarters · filed 2024-02-29 | $59.19M derived: sum of 3 quarters · filed 2024-02-29 | $59.19M 10-K · filed 2024-02-29 |
| 2021-09-30 | $49.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $49.55M derived: sum of 2 quarters · filed 2022-11-08 | $49.55M 10-Q · filed 2022-11-08 | $49.57M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $12.00K derived: sum of 3 quarters · filed 2023-03-01 | $27.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-10 | $13.00K derived: sum of 2 quarters · filed 2023-03-01 | $28.00K derived: sum of 3 quarters · filed 2023-03-01 | $103.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $27.00K derived: sum of 2 quarters · filed 2023-03-01 | $102.00K derived: sum of 3 quarters · filed 2023-03-01 | $2.21M 10-K · filed 2023-03-01 |
| 2020-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $90.00K derived: sum of 2 quarters · filed 2021-11-04 | $2.19M 10-Q · filed 2021-11-04 | $6.51M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $2.18M 10-Q · filed 2021-08-05 | $6.50M derived: sum of 3 quarters · filed 2022-02-28 | $11.70M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $2.10M 10-Q · filed 2021-05-10 | $6.42M derived: sum of 2 quarters · filed 2022-02-28 | $11.63M derived: sum of 3 quarters · filed 2022-02-28 | $13.85M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.52M derived: sum of 2 quarters · filed 2022-02-28 | $11.74M derived: sum of 3 quarters · filed 2022-02-28 | $22.70M 10-K · filed 2022-02-28 |
| 2019-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $7.42M derived: sum of 2 quarters · filed 2020-11-06 | $18.38M 10-Q · filed 2020-11-06 | $22.05M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.18M 10-Q · filed 2020-08-06 | $16.85M derived: sum of 3 quarters · filed 2021-03-12 | $22.04M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $10.95M 10-Q · filed 2020-05-08 | $14.63M derived: sum of 2 quarters · filed 2021-03-12 | $19.82M derived: sum of 3 quarters · filed 2021-03-12 | $30.48M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $8.86M derived: sum of 2 quarters · filed 2021-03-12 | $19.52M derived: sum of 3 quarters · filed 2021-03-12 | $19.62M 10-K · filed 2021-03-12 |
| 2018-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $15.85M derived: sum of 2 quarters · filed 2019-11-08 | $15.95M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $10.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $10.76M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $94.00K 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $22.54M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |